Historical record - last NADAC effective date: 8/18/2021

Product Information

PIROXICAM 20 MG CAPSULE is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.4615 per EA under NDC 29300025605. Its NADAC has been published 189 times since Jan 10, 2018.

FDA first approved this application on Apr 13, 2017.

The High Outlier badge above means this manufacturer's average price in the Piroxicam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PIROXICAM 20 MG CAPSULE

Piroxicam
$0.4615per EA
High Outlier

Strength

20 mg/1

NDC

29300025605

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/18/2021

Active Ingredients

PIROXICAM

Approval Type

Generic (ANDA)

FDA Application

ANDA208340

FDA Approved

4/13/2017

On Market Since

8/1/2017

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for PIROXICAM 20 MG CAPSULE has been published 189 times since Jan 10, 2018, and over the history we have for it it has declined 54.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4615 per EA
All-time high$1.0113 (Jan 10, 2018)
All-time low$0.3749 (Aug 19, 2020)
Median price$0.5142
Average price$0.5623
Largest weekly change+53.6% (May 19, 2021)
Weeks tracked189
Tracking sinceJan 10, 2018

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-54.4%

Last surveyed Aug 18, 2021 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIROXICAM 20 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PIROXICAM 20 MG CAPSULE, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.4615 per EA (NDC 29300025605), effective Aug 18, 2021.

How has the price of PIROXICAM 20 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PIROXICAM 20 MG CAPSULE has declined 54.4%. It has been tracked across 189 weekly CMS publications since Jan 10, 2018.

What are the highest and lowest recorded NADAC prices for PIROXICAM 20 MG CAPSULE?

Since Jan 10, 2018, the NADAC for PIROXICAM 20 MG CAPSULE has ranged from a low of $0.3749 (Aug 19, 2020) to a high of $1.0113 (Jan 10, 2018), with a median of $0.5142 per EA.

Are there cheaper alternatives to PIROXICAM 20 MG CAPSULE?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PIROXICAM 20 MG CAPSULE, is $0.2240 per EA — about 51% below PIROXICAM 20 MG CAPSULE.

Who manufactures PIROXICAM 20 MG CAPSULE?

PIROXICAM 20 MG CAPSULE (NDC 29300025605) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.